3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
3
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Breast Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Prostate Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Male Urogenital Diseases
1
Lymphedema
1
Lung Neoplasms
1
Gallbladder Neoplasms
1
Financial Stress
1
Female Urogenital Diseases
1
Endometrial Neoplasms
1
Encopresis
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Carcinoma In Situ
1
Interventions
pembrolizumab
26
Paclitaxel
25
Carboplatin
19
Bevacizumab
13
Specimen Handling
11
Magnetic Resonance Spectroscopy
9
Doxorubicin
8
Cisplatin
8
Taxes
7
Biopsy
7
olaparib
6
lenvatinib
6
Fulvestrant
6
durvalumab
5
dostarlimab
5
Nivolumab
5
Megestrol Acetate
5
Letrozole
5
Gemcitabine
5
Docetaxel
5
trastuzumab deruxtecan
4
Trastuzumab
4
Tirzepatide
4
Progestins
4
Medroxyprogesterone Acetate
4
Fluorouracil
4
palbociclib
3
ipatasertib
3
atezolizumab
3
abemaciclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Radiation Dose Hypofractionation
×
90 days
×
Clear all
NCT07595224
2026-05-19
PostOP HYPOCxE
Siriraj Hospital
Phase NA
Recruiting
120 enrolled